Page last updated: 2024-08-24

imiquimod and Carcinoma, Ductal, Breast

imiquimod has been researched along with Carcinoma, Ductal, Breast in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahoric, B; Basik, M; Batist, G; Guay, MP; Henriques, L; Kavan, P; Palumbo, M	1
Carson, J; Jenkinson, H; O'Kane, D	1
Bonnekoh, B; Fehsecke, D; Franke, I; Froster, UG; Gollnick, HP; Helmdach, M; Kraus, C; Quist, SR; Reis, A	1
Adams, S; Axelrod, D; Bhardwaj, N; Chiriboga, L; Demaria, S; Formenti, SC; Goldberg, JD; Hochman, T; Kozhaya, L; Liebes, L; Martiniuk, F; Meng, TC; Novik, Y; Shuman, N; Speyer, J; Tiersten, A; Unutmaz, D	1
Kohrt, H	1

Reviews

1 review(s) available for imiquimod and Carcinoma, Ductal, Breast

Article	Year
Langerhans cell histiocytosis associated with breast carcinoma successfully treated with topical imiquimod. Clinical and experimental dermatology, 2009, Volume: 34, Issue:8 Topics: Adjuvants, Immunologic; Aminoquinolines; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Histiocytosis, Langerhans-Cell; Humans; Imiquimod; Middle Aged; Treatment Outcome	2009

Trials

1 trial(s) available for imiquimod and Carcinoma, Ductal, Breast

Article	Year
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cytokines; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Treatment Outcome; Tumor Microenvironment	2012

Article

Year

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24

Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cytokines; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Treatment Outcome; Tumor Microenvironment

2012

Other Studies

3 other study(ies) available for imiquimod and Carcinoma, Ductal, Breast

Article	Year
Imiquimod in the treatment of breast cancer skin metastasis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Mar-10, Volume: 32, Issue:8 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease Progression; Fatal Outcome; Female; Humans; Imiquimod; Pain; Skin Neoplasms; Treatment Outcome	2014
Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer. Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:3 Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Imiquimod; Middle Aged; Patched Receptors; Receptors, Cell Surface; Scalp; Skin Neoplasms	2011
Breast cancer treatment with imiquimod: applying an old lotion to a new disease. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Imiquimod; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Skin Neoplasms; Toll-Like Receptor 7	2012